Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_assertion type Assertion NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_head.
- NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_assertion description "[Most of the results described above were obtained in CRC; however, when we extended our observations to tumor cell lines of different origin, we found that SMYD3 inhibitors are also effective in other cancer types, such as lung, pancreatic, prostate, and ovarian.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_provenance.
- NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_assertion evidence source_evidence_literature NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_provenance.
- NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_assertion SIO_000772 25728514 NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_provenance.
- NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_assertion wasDerivedFrom befree-2016 NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_provenance.
- NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_assertion wasGeneratedBy ECO_0000203 NP1267268.RApQVZa0Rn9xCKvegVgUKmxuCEt8_CApv51smoea7F9gw130_provenance.